Sign In
Buy OMCL
$41.89
-0.0200 (-0.0477%)
At Close: Jun 03, 2026
Omnicell, Inc. (OMCL) Q3 2025 Earnings Call Transcript
03:36pm, Thursday, 30'th Oct 2025
Omnicell, Inc. ( OMCL ) Q3 2025 Earnings Call October 30, 2025 8:30 AM EDT Company Participants Kathleen Nemeth - Senior Vice President of Investor Relations Randall Lipps - Founder, Executive Chairma
Omnicell (OMCL) Q3 Earnings and Revenues Surpass Estimates
08:46am, Thursday, 30'th Oct 2025
Omnicell (OMCL) came out with quarterly earnings of $0.51 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.56 per share a year ago.
Omnicell Announces Third Quarter 2025 Financial Results
06:30am, Thursday, 30'th Oct 2025
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces Third Quarter 2025 Financial Results.
Wall Street Analysts See a 43.74% Upside in Omnicell (OMCL): Can the Stock Really Move This High?
10:56am, Friday, 24'th Oct 2025
The average of price targets set by Wall Street analysts indicates a potential upside of 43.7% in Omnicell (OMCL). While the effectiveness of this highly sought-after metric is questionable, the posit
Earnings Preview: Omnicell (OMCL) Q3 Earnings Expected to Decline
11:07am, Thursday, 23'rd Oct 2025
Omnicell (OMCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are Investors Undervaluing Omnicell (OMCL) Right Now?
10:41am, Thursday, 23'rd Oct 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Omnicell (OMCL) to Release Earnings on Thursday
02:38am, Thursday, 23'rd Oct 2025
Omnicell (NASDAQ: OMCL - Get Free Report) will likely be posting its Q3 2025 results before the market opens on Thursday, October 30th. Analysts expect Omnicell to post earnings of $0.36 per share and
OMCL or HIMS: Which Is the Better Value Stock Right Now?
12:40pm, Friday, 17'th Oct 2025
Investors with an interest in Medical Info Systems stocks have likely encountered both Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two stocks is more attractive to value in
Is Omnicell (OMCL) Stock Undervalued Right Now?
10:41am, Tuesday, 07'th Oct 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Reasons to Add Omnicell Stock to Your Portfolio Right Now
09:26am, Tuesday, 07'th Oct 2025
OMCL's expanding SaaS portfolio, overseas growth plans, and solid balance sheet position it for sustained momentum despite rising competition.
Omnicell to Release Third Quarter 2025 Financial Results on October 30, 2025
04:01pm, Monday, 06'th Oct 2025
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Release Third Quarter 2025 Financial Results on October 30, 2025.
OMCL or HIMS: Which Is the Better Value Stock Right Now?
12:41pm, Wednesday, 01'st Oct 2025
Investors with an interest in Medical Info Systems stocks have likely encountered both Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two stocks presents investors with the be
Is Omnicell (OMCL) a Great Value Stock Right Now?
10:41am, Thursday, 18'th Sep 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
OMCL or HIMS: Which Is the Better Value Stock Right Now?
12:41pm, Monday, 15'th Sep 2025
Investors with an interest in Medical Info Systems stocks have likely encountered both Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two companies is the best option for thos
NVIDIA, AI & Quantum Leaders Drive Health Tech: 2 Stocks to Buy
04:01pm, Thursday, 11'th Sep 2025
Butterfly Network and Omnicell emerge as standout health tech stocks as AI and quantum breakthroughs reshape diagnostics and medication management.
